Medplus is established in 2006 by Gangadi Madhukar Reddy, Lone Furrow Investments Pvt Ltd, and Agilemed Investments Pvt Ltd are the promoters of the company.
Medplus IPO: The vision to set up a trusted pharmacy retail brand that offers genuine medicines and delivers better value to the customer by reducing inefficiencies in the supply chain using technology. The founder, Managing Director and Chief Executive Officer of our Company, Gangadi Madhukar Reddy, both a doctor and an entrepreneur, plays an instrumental role in the strategic direction and growth of our business. The Company’s shareholders include marquee investors, including Lavender Rose, belonging to the Warburg Pincus group, and affiliates of Premji Invest, and we maintain strong corporate governance and internal controls.
The company operate 2,165 stores in 242 cities distributed across Tamil Nadu, Andhra Pradesh, Telangana, Karnataka, Odisha, West Bengal and Maharashtra as of June 30, 2021. They have a total of 14,762 permanent full-time in-house employees working for us in a range of business activities.
The operations include the manufacturing and contract manufacturing of private label pharmaceutical, wellness and FMCG products, wholesale and retail sale, import, distribution, and pathology diagnostic laboratory testing.
The omni-channel platform enables us to service our customers through our stores as well as our online channels, thereby enabling us to leverage our strong offline channel to establish and grow our online presence.
| Medplus IPO Details | |
| IPO Opening Dates | 13-December-2021 |
| IPO Closing Dates | 15-December-2021 |
| Price Band | 780-796 Rs |
| Offer For Sale | 798.30 Crore |
| Fresh issue | 600.00 Crore |
| Total IPO size | 1,398.30 Crore |
| Minimum bid (lot size) | 18 Shares |
| Face Value | 2 Rs Per Share |
| Retail Allocation | 35% |
| Listing On | NSE, BSE |
| Medplus IPO Market Lot | |||
| Lot | No of Shares | Amount | |
| Minimum | 1 | 18 | 14,328 Rs |
| Maximum | 13 | 234 | 1,86,264 |
Financial Record of the last year (In Millions)
Financial Period : 30-Sep-2021 (Restated Consolidated)
Total Assets : 17,464.94
Total Revenue : 18,908.99
Profit After Tax : 663.67
Basic Earnings Per Share (EPS) FY2021 : 5.88 INR
Medplus IPO GMP & Grey Market Premium
Check Medplus Health IPO Grey Market Activities Day By Day
Medplus IPO Subscription Status
Check Medplus IPO Subscription Status
Medplus IPO DRHP
Medplus IPO Reviews
Prabhudas Lilladher –
Angel One –
Anand Rathi –
Marwadi Financial Services –
Medplus IPO Allotment Date & Details
| Allotment Date | 20-December-2021 |
| Initiation of refunds | 21-December-2021 |
| Transfer of shares to Demat accounts | 22-December-2021 |
| Listing Date | 23-December-2021 |
| Check Allotment Status | Click here |
Registrar of Medplus IPO
KFin Technologies Private Limited
Selenium, Tower B, Plot No- 31 and 32,
Financial District, Nanakramguda,
Serilingampally, Hyderabad, Rangareedi 500 032,
Telangana, India
Tel: +91 40 6716 2222/ 180034 54001
E-mail: [email protected]
Investor grievance e-mail:
[email protected]
Website: www.kfintech.com
Contact person: M Murali Krishna
SEBI Registration No.: INR000000221
Medplus Contact Details
Medplus Health Services Limited
707, 7th Floor, 5-9-13,
Taramandal Commercial Complex, Saifabad
Hyderabad 500 004
Phone: +91 040 6724 6724
Email: [email protected]
Website: http://www.medplusindia.com/
